Epidemiological characteristics, genotype patterns, and treatment outcomes in chronic hepatitis C patients receiving direct-acting antivirals: a cohort study from Istanbul, Türkiye

Abstract Introduction We aimed to evaluate the real-world effectiveness and safety of direct-acting antiviral agents (DAAs) in patients with chronic hepatitis C (CHC) and to describe genotype distribution. Methods Patients diagnosed with CHC and treated with DAAs between June 2016 and January 2023 w...

Descrición completa

Detalles Bibliográficos

Principais autores:	Semra Karaman Kamalı, Sevtap Senoglu, Sercan Kamalı, Yusuf Emre Ozdemir, Kadriye Kart Yasar
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-02-01
Series:	BMC Infectious Diseases
Assuntos:	Chronic hepatitis C Direct-acting antiviral agents Genotype distribution Rapid virological response Sustained virological response
Acceso en liña:	https://doi.org/10.1186/s12879-026-12850-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!